Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| OCG | Oriental Culture Ltd | $2.27 | -$6.43 | -73.91% | 5.5M | $184.7M | $1.09$19.29 |
| BBGI | Beasley Broadcast Group | $9.51 | -$7.18 | -43.02% | 2.5M | $30.1M | $3.67$26.37 |
| ASPC | A Spac III Acquisition Corp. | $11.49 | -$5.32 | -31.65% | 108.5K | $39.3M | $9.95$63.98 |
| ORCX | Tidal Trust II - Defiance Daily Target 2x Long Orcl ETF | $17.19 | -$6.28 | -26.76% | 13.2M | - | $9.05$60.53 |
| ORCU | Direxion Shares ETF Trust - Daily Orcl Bull 2x Etf | $18.42 | -$6.69 | -26.64% | 1.4M | - | $16.81$27.62 |
| SKIL | Skillsoft | $5.91 | -$1.80 | -23.40% | 511.8K | $67.2M | $4.65$34.43 |
| XOMA | XOMA | $26.60 | -$7.76 | -22.58% | 156.2K | $425.5M | $18.35$39.92 |
| FBYD | Falcon's Beyond Global | $13.41 | -$3.53 | -20.82% | 93.3K | $630.6M | $3.62$29.02 |
| OXM | Oxford Industries | $32.45 | -$8.00 | -19.77% | 1.3M | $601.4M | $30.57$89.86 |
| HSPO | Horizon Space Acquisition I Corp. | $12.33 | -$2.69 | -17.91% | 36K | $36.1M | $11.33$29.64 |
Related Articles
Featured Article
1 Brand-New Big Reason to Buy This Biotech Stock Right Now
Alex Carchidi|Oct 24, 2024
This stock currently has a good balance of risk and potential rewards.

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
Alex Carchidi|Oct 3, 2024
These two could become direct competitors relatively soon.

2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
Alex Carchidi|Sep 19, 2023
The gene-editing market is moving fast, and it pays to get to know some of these companies.

Advertisement
3 Luxury Stocks That Long-Term Investors Should Love
Michael Byrne|Dec 16, 2022
The luxury space is a good place for investors to be heading into next year.

Kick Your Feet Up with Shares of This Luxury Apparel Stock
Michael Byrne|Dec 15, 2022
Oxford Industries owns such popular brands as Tommy Bahama, Southern Tide, and Lily Pulitzer.

This Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream
Jeffrey Little|Oct 2, 2021
Pre-clinical successes lead to exclusive licensing agreements for iBio.

These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
Alex Carchidi|Jan 1, 2021
Innovation paid off big for investors.

Is It Too Late to Buy iBio Stock?
Zhiyuan Sun|Oct 29, 2020
The time to make money by investing in iBio is over. Here's why that's good news.

3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year
Keith Speights|Oct 8, 2020
Here's what it would take.

3 Compelling Biotech Stocks to Consider Buying While They're Hot on Robinhood
Alex Carchidi|Sep 20, 2020
These companies are certainly risky, but they might have what it takes to deliver serious growth for investors.
